Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $126.68 USD
Change Today +2.64 / 2.13%
Volume 901.2K
As of 3:00 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ian F. Smith CPA, ACA

Chief Financial Officer and Executive Vice President,Vertex Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 50 board members in 4 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Ian F. Smith, CPA, ACA, has been the Chief Financial Officer of Vertex Pharmaceuticals Incorporated since October 2001 and has been its Executive Vice President since February 2006. Mr. Smith serves as a Member of the Executive Team of Vertex Pharmaceuticals Incorporated and holds responsibility for a wide variety of core functions, including Finance, Strategic Communications, Information Systems, Operations and Human Resources. He served as a Senior Vice President ...

Read Full Background

Corporate Headquarters*

50 Northern Avenue
Boston, Massachusetts 02210

United States

Phone: 617-341-6100
Fax: --

Board Members Memberships*

Director and Member of Audit Committee
Independent Director and Chairman of Audit Committee
Director, Chairman of Audit Committee and Member of Nominations & Governance Committee
Director and Chairman of Audit Committee


Manchester Metropolitan University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$650,000

Stock Options*

Restricted Stock Awards$9,865,110
All Other Compensation$12,857
Exercised Options107,624
Exercised Options Value$7,598,771
Exercisable Options50,420
Exercisable Options Value$2,857,403
Unexercisable Options184,133
Unexercisable Options Value$9,287,706
Total Value of Options$19,743,880
Total Number of Options342,177

Total Compensation*

Total Annual Cash Compensation$1,394,107
Total Short Term Compensation$650,000
Other Long Term Compensation$9,877,967
Total Calculated Compensation$15,303,863
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRTX:US $126.68 USD +2.64


Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
Jean-Jacques Bienaime MBAChairman and Chief Executive Officer
BioMarin Pharmaceutical Inc.
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at